Osteoclast intracellular ATP-dependent processes

Osteoclast intracellular ATP-dependent processes refers to the suite of metabolic and enzymatic activities within bone-resorbing osteoclasts that rely on adenosine triphosphate (ATP) for energy and signaling (Rogers et al., 2011, Bone). This functional target is specifically relevant to the pharmacology of non-nitrogen-containing bisphosphonates (non-N-BPs), such as clodronate and etidronate (Frith et al., 1997, Journal of Bone and Mineral Research). These drugs are metabolically incorporated into non-hydrolyzable ATP analogues, most notably adenosine 5'-(beta,gamma-dichloromethylene) triphosphate (ApppI), which accumulate to high levels within the osteoclast cytoplasm (Lehenkari et al., 1998, Molecular Pharmacology). These analogues competitively inhibit various ATP-dependent enzymes and transporters, including the mitochondrial adenine nucleotide translocase (ANT), which disrupts mitochondrial function and triggers programmed cell death (apoptosis) (Benford et al., 2001, Journal of Bone and Mineral Research). By inducing osteoclast apoptosis, these agents effectively suppress excessive bone resorption, making them useful in the management of metabolic bone diseases like osteoporosis and Paget's disease (Drake et al., 2008, Mayo Clinic Proceedings).

Other names

ATP-dependent enzymesOsteoclast ATP metabolismNon-nitrogenous bisphosphonate target pathway

Non-nitrogenous bisphosphonates are metabolized into non-hydrolyzable ATP analogues (ApppI) that inhibit ATP-dependent enzymes and mitochondrial function, leading to osteoclast apoptosis (Rogers et al., 2011, Bone).